Market Trading Guide: Buy Policybazaar, EPL and 2 more smallcap stocks on Wednesday. Up to 9% upside seen
1/5
Stock Ideas
India’s headline indices ended Tuesday with decline amid selling pressure in banks and financial stocks as uncertainties surrounding tariffs and geopolitical issues continued to weigh on Indian equities. The index slipped from the day’s high of 24,700, closing more than 200 points lower.
Commenting on the day’s action, Rupak De, Senior Technical Analyst at LKP Securities said that the Nifty index is likely to remain volatile with no clear directional bias in the short term.
"On the downside, immediate support is placed at 24,450; a break below this level could drag it towards 24,337 or lower. On the upside, immediate resistance is seen at 24,660–24,700, and a sustained move above this zone could push it towards 24,850 or even 25,000," De said.
Here are 4 stock recommendations for Wednesday:
Commenting on the day’s action, Rupak De, Senior Technical Analyst at LKP Securities said that the Nifty index is likely to remain volatile with no clear directional bias in the short term.
"On the downside, immediate support is placed at 24,450; a break below this level could drag it towards 24,337 or lower. On the upside, immediate resistance is seen at 24,660–24,700, and a sustained move above this zone could push it towards 24,850 or even 25,000," De said.
Here are 4 stock recommendations for Wednesday:
2/5
Buy Zota Health at Rs 1,332.50 | Upside: 9%
Stop Loss: Rs 1,270
Target: Rs 1,400/1,450
Zota Health Care has formed a higher-high, higher-low structure, consolidating in a m tight range before giving a breakout with a strong bullish candle backed by large volumes. The price has sustained above key EMAs, reflecting a strong underlying trend. RSI at 71.56 indicates robust bullish momentum, while ADX at 36.15 confirms a strengthening trend. This technical setup signals potential for continued upside, and a buy recommendation is given in the 1,320-1,330 range with a stop loss at 1,270 (closing basis) and targets of 1,400-1,450.
(Drumil Vithlani, Technical Research Analyst at Bonanza)
Target: Rs 1,400/1,450
Zota Health Care has formed a higher-high, higher-low structure, consolidating in a m tight range before giving a breakout with a strong bullish candle backed by large volumes. The price has sustained above key EMAs, reflecting a strong underlying trend. RSI at 71.56 indicates robust bullish momentum, while ADX at 36.15 confirms a strengthening trend. This technical setup signals potential for continued upside, and a buy recommendation is given in the 1,320-1,330 range with a stop loss at 1,270 (closing basis) and targets of 1,400-1,450.
(Drumil Vithlani, Technical Research Analyst at Bonanza)
3/5
Buy Choice International at Rs 789.15 | Upside: 8%
Stop Loss: Rs 750
Target: Rs 820/850
Choice International has witnessed a range breakout with a strong bullish candle backed by above-average volumes, indicating fresh accumulation. The stock is trading comfortably above its key EMAs, highlighting a strong underlying uptrend. RSI at 69.16 reflects healthy bullish momentum, while ADX at 32.23 confirms a strengthening trend structure. Given this breakout from consolidation, a buy is advised in the 8780-1785 zone with a stop loss at 1750 (closing basis) and upside targets of 820-850.
(Drumil Vithlani, Technical Research Analyst at Bonanza)
Target: Rs 820/850
Choice International has witnessed a range breakout with a strong bullish candle backed by above-average volumes, indicating fresh accumulation. The stock is trading comfortably above its key EMAs, highlighting a strong underlying uptrend. RSI at 69.16 reflects healthy bullish momentum, while ADX at 32.23 confirms a strengthening trend structure. Given this breakout from consolidation, a buy is advised in the 8780-1785 zone with a stop loss at 1750 (closing basis) and upside targets of 820-850.
(Drumil Vithlani, Technical Research Analyst at Bonanza)
Amazon Top Deals
POWERED BY
4/5
Buy Policybazaar at Rs 1,825 | Upside: 8%
Stop Loss: Rs 1,735
Target: Rs 1,975
Buy PB Fintech with a timeframe of 2-3 weeks. The down trend of the last 2 months seems to have reversed up so far this week. We observed a formation of a crucial bottom reversal pattern at Rs 1,725 recently. The stock price has broken above the hurdle of down sloping trend line on Monday and is presently showing consolidation movement. Volume has started to expand during upside breakout in the stock price and daily RSI shows positive indication.
(Nagaraj Shetti, Senior Technical Research Analyst at HDFC Securities)
Target: Rs 1,975
Buy PB Fintech with a timeframe of 2-3 weeks. The down trend of the last 2 months seems to have reversed up so far this week. We observed a formation of a crucial bottom reversal pattern at Rs 1,725 recently. The stock price has broken above the hurdle of down sloping trend line on Monday and is presently showing consolidation movement. Volume has started to expand during upside breakout in the stock price and daily RSI shows positive indication.
(Nagaraj Shetti, Senior Technical Research Analyst at HDFC Securities)
5/5
Buy EPL at Rs 231.50 | Upside: 8%
Stop Loss: Rs 220
Target: Rs 250
Buy with a timeframe of 2-3 weeks. The stock price was in a gradual upside momentum over the last few sessions. We observe bullish patterns like higher tops and bottoms over the period of time. Currently, placed near the upside breakout of larger consolidation band at Rs 235-240 levels. Volume and RSI patterns indicate positive bias for the stock price ahead.
(Nagaraj Shetti, Senior Technical Research Analyst at HDFC Securities)
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)
Target: Rs 250
Buy with a timeframe of 2-3 weeks. The stock price was in a gradual upside momentum over the last few sessions. We observe bullish patterns like higher tops and bottoms over the period of time. Currently, placed near the upside breakout of larger consolidation band at Rs 235-240 levels. Volume and RSI patterns indicate positive bias for the stock price ahead.
(Nagaraj Shetti, Senior Technical Research Analyst at HDFC Securities)
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)